Kiniksa Pharmaceuticals
KNSA
KNSA
104 hedge funds and large institutions have $383M invested in Kiniksa Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 38 increasing their positions, 27 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
13% more funds holding
Funds holding: 92 → 104 (+12)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.5% less ownership
Funds ownership: 87.3% → 86.8% (-0.5%)
Holders
104
Holding in Top 10
1
Calls
$4.68M
Puts
$1.79M
Top Buyers
| 1 | +$11.8M | |
| 2 | +$8.75M | |
| 3 | +$4.8M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$4.08M |
| 5 |
Goldman Sachs
New York
|
+$3.48M |
Top Sellers
| 1 | -$11.7M | |
| 2 | -$7.89M | |
| 3 | -$6.34M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$3.23M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$2.86M |